Neuromyelitis Optica Spectrum Disorder News and Research

RSS
Cytel hosts Complex Innovative Trial Design Symposium and East Training in Boston

Cytel hosts Complex Innovative Trial Design Symposium and East Training in Boston

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Study highlights possible reasons for MS misdiagnosis

Study highlights possible reasons for MS misdiagnosis

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder

International consensus panel reviews new diagnostic criteria for neuromyelitis optica spectrum disorder